New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 20, 2014
07:56 EDTAZN, T, LAZ, PFE, BAC, DTV, JPMLazard shares rise after AT&T mega-deal struck, WSJ says
Shares of Lazard (LAZ) rose yesterday after AT&T (T), which Lazard was the advisor for, announced its deal to acquire DirecTV (DTV), reported The Wall Street Journal. In contrast, JPMorgan (JPM), Bank of America (BAC) and Guggenheim Partners look set to be disappointed and lose out on potential fees as Pfizer's (PFE) bid for AstraZeneca (AZN) appears destined to fail, the report noted. The Journal added that the total value of agreed-upon U.S. deals is up 87% from last year to $585B year-to-date. Reference Link
News For LAZ;JPM;BAC;T;DTV;PFE;AZN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
April 14, 2015
07:10 EDTJPMJPMorgan up 0.5% to $62.35 in pre-market following Q1 report
Subscribe for More Information
07:08 EDTJPMJPMorgan reports Q1 Basel III common equity Tier 1 ratio 10.6%
Subscribe for More Information
07:06 EDTJPMJPMorgan CEO says franchise getting safer, stronger
Jamie Dimon, JPMorgan Chairman and CEO, said: JPMorgan Chase continues to support consumers, businesses and communities and make a significant positive impact. We have an outstanding franchise which is getting safer and stronger, and is gaining market share over time. We continue to build the company for the long-term, we are investing in controls, infrastructure, systems, technology, new products and bankers. We will continue to navigate challenges and deliver for our clients, shareholders and communities.
07:03 EDTJPMJPMorgan reports tangible book value per share up 9% to $45.45
Subscribe for More Information
07:01 EDTJPMJPMorgan says Q1 results include $487M, or 13c, significant item legal expense
Subscribe for More Information
07:00 EDTJPMJPMorgan reports Q1 EPS $1.45, consensus $1.40
Reports Q1 GAAP revenue $24.1B, consensus $24.5B. Reports Q1 managed basis revenue $24.82B.
April 13, 2015
20:16 EDTTUSTelecom files net neutrality lawsuit against FCC
Subscribe for More Information
16:21 EDTJPMOn The Fly: Top stock stories for Monday
Subscribe for More Information
15:38 EDTJPMNotable companies reporting before tomorrow's open
Subscribe for More Information
15:18 EDTJPMJPMorgan technical notes ahead of earnings
The shares are trading close to the 52-week high which is at $63.49. On strongly positive news, the stock would be pushed toward the life high at $67.17. That would be an important technical milestone if it was reached. Traders should note however that that move would on a long-term basis appear as a move up to prior resistance without being a bullish breakout. Until or if there is a breakout above the old life high, there is retracement risk even on good results. On news that is more bearish than current expectations would suggest, first major support would be at the 50-day moving average at $60.10. On a move below that level, next support would be at $57.87.
15:12 EDTPFEMylan enters settlement, license agreement with Pfizer regarding Viagra
Mylan (MYL) announced that its subsidiaries Mylan Inc. and Mylan Pharmaceuticals have entered into a settlement and license agreement with Pfizer (PFE), Pfizer Limited and Pfizer Ireland Pharmaceuticals to settle patent litigation relating to Mylan's Abbreviated New Drug Application filed with the U.S. FDA for Sildenafil Citrate Tablets 25 mg, 50 mg, and 100 mg. This product is the generic version of Viagra, which is indicated to treat erectile dysfunction. Under the terms of the agreement, Mylan will be able to launch its ANDA products pursuant to a royalty-bearing license as early as December 11, 2017, or sooner under certain conditions, subject to FDA approval. All other terms and conditions of the settlement and license agreement are confidential, and the agreement itself is subject to review by the U.S. Department of Justice and the Federal Trade Commission. For the 12 months ending Dec. 31, 2014, Viagra had U.S. sales of approximately $1.3B, according to IMS Health.
15:10 EDTJPMJPMorgan April 62 straddle priced for 2.6% movement into Q1
Subscribe for More Information
13:57 EDTJPMEarnings Watch: Analysts upbeat on JPMorgan ahead of Q1 results
Subscribe for More Information
11:12 EDTJPMJP Morgan April volatility elevated into Q1 and outlook
Subscribe for More Information
10:00 EDTLAZOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:24 EDTBACBank of America shares are cheap, says Morgan Stanley
Morgan Stanley said its sum of the parts of analysis of Overweight rated Bank of America indicates a value of $21. The firm said Bank of America's current share price implies no value for the wealth management division, which it values at $4.84 per share. Morgan Stanley said shares are cheap and recommends purchase.
09:04 EDTLAZLazard downgraded to Hold from Buy at Sandler O'Neill
Subscribe for More Information
08:58 EDTAZNMerck may have positive read through from briefing docs, says SunTrust
Subscribe for More Information
08:54 EDTAZNAstraZeneca has negative read through from briefing docs, says SunTrust
Subscribe for More Information
07:19 EDTBACbloomberg to hold a summit
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use